ACET vs EW · $75.7M cap vs P/E 47, rev $1.39B
Adicet Bio Inc (ACET) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Adicet Bio Inc (ACET) is a biotechnology company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
ACET does not have a complete income-statement cache yet.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ACET currently screens at market cap $75.7M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ACET and EW stock pages for the full models.
Not investment advice.